Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AGCO Corporation (AGCO) vs McKesson Corporation (MCK) Price & Performance

AGCO Corporation
McKesson Corporation

Price performance

Price movement over the last 24 hours

Key statistics

AGCO Corporation vs McKesson Corporation — how do they compare? AGCO Corporation trades at $113.41 (market cap $8.24B), while McKesson Corporation trades at $817.75 (market cap $94.52B). The key difference: McKesson Corporation is far larger — about 11.5× AGCO Corporation's market cap, and AGCO Corporation pays the higher dividend (1.05%). Which is the better fit depends on your goals.

AGCOMCK
Market Cap
$8.24B$94.52B
Sector
IndustrialsHealth
52-Week High
$140.49$995.69
52-Week Low
$100.14$659.01
Enterprise Value
$10.41B$99.16B
Dividend Yield
1.05%0.41%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AGCO Corporation

Agco is a global manufacturer of agricultural equipment. The company has five principal brands: Fendt, Massey Ferguson, Challenger, Valtra, and GSI. Unlike its competitors, Agco's product line extends beyond self-propelled equipment and implements by offering grain handling systems and livestock management solutions. Its products are available through a global dealer network, which includes over 3,200 dealer and distribution locations. Additionally, Agco offers both retail and wholesale financing to customers through its joint venture with Rabobank, a European food and agriculture focused bank.

Read more on AGCO

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK